George Yancopoulos - Jun 10, 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Bd. Co-Chair, President & CSO, Director
Signature
By: Richard Gluckselig as attorney-in-fact For: George D. Yancopoulos
Stock symbol
REGN
Transactions as of
Jun 10, 2024
Transactions value $
$0
Form type
4
Date filed
6/12/2024, 04:10 PM
Previous filing
May 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Gift $0 -75.8 K -100% $0.00 0 Jun 10, 2024 by 2022 GRAT II
transaction REGN Common Stock Gift $0 +37.9 K +208.84% $0.00 56 K Jun 10, 2024 by Children
holding REGN Common Stock 869 K Jun 10, 2024 Direct
holding REGN Common Stock 5.9 K Jun 10, 2024 By 401(k) Plan
holding REGN Common Stock 180 K Jun 10, 2024 By Trust for Chldn. F1

Explanation of Responses:

Id Content
F1 As investment trustee of trusts for the benefit of the reporting person's children.